Unique Controlled Expansion of Supercritical Solutions (CESS®) technology for poorly soluble APIs
Dr Satu Lakio
Nanoform Finland Ltd

Dr Satu Lakio works in the field of supercritical fluid.  She received her PhD from University of Helsinki and then moved to Melbourne for a postdoc. She has held several positions in both industry and Academia including in AstraZeneca, Orion Pharma, the University of Helsinki, and University of Eastern Finland.  Currently she is working as Pharmaceutical Development Manager at Nanoform where she utilises supercritical carbon dioxide to produce nanoparticles with improved dissolution profiles. Many thanks Dr Lakio for agreeing to present in our conference, her talk will discuss Unique Controlled Expansion of Supercritical Solutions (CESS®) technology for poorly soluble APIs.

An event organised by the Royal Society of Chemistry's Formulation Science & Technology (FST) Interest Group.